Zhang, J. 2024. FDX1 is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients with Kidney Clear Cell Carcinoma. Annals of King Edward Medical University. 30, 4 (Dec. 2024), 334–343. DOI:https://doi.org/10.21649/akemu.v30i4.5531.